Keyphrases
Cost-effectiveness
100%
Clinical Efficacy
100%
Economic Evaluation
100%
Primary Open-angle Glaucoma
100%
Clinical Costs
100%
Review Evaluation
100%
Randomized Controlled Trial
60%
Pounding
60%
Population Screening
60%
Screening Test
60%
Screening Strategy
60%
Highly Sensitive
40%
Visual Impairment
40%
40 Years Old
40%
Parameter Estimation
40%
Progression Rate
40%
Risk of Progression
40%
Older Cohort
40%
Economic Model
40%
Screening Interval
40%
Health Outcomes
20%
Societal Costs
20%
Disease Severity
20%
Service Provision
20%
Early Treatment
20%
Diabetes
20%
High Prevalence
20%
Markov
20%
Epidemiology
20%
50 Years Old
20%
Organizational Change
20%
Adequate Service
20%
National Screening
20%
Screening Program
20%
Glaucoma
20%
Family History
20%
Technology-based
20%
Quality-adjusted Life Years
20%
Willingness to Pay
20%
Effectiveness Study
20%
First Assessments
20%
Electronic Search
20%
Blindness
20%
High-risk Population
20%
Model Estimates
20%
Selective Screening
20%
Automated Classification
20%
At-risk
20%
Targeted Screening
20%
Health Risk
20%
Test Accuracy
20%
Glaucoma Prevalence
20%
NHS Costs
20%
Specific Tests
20%
Utility Value
20%
Myopia
20%
Black Ethnicity
20%
Glaucoma Screening
20%
Test Screening
20%
Test Treatments
20%
Eye Examination
20%
Current Test
20%
Heterogeneous Studies
20%
Community Eye Health
20%
Glaucoma Detection
20%
Program Services
20%
Time to Blindness
20%
Sight Test
20%
Eye Care Services
20%
Base-case Model
20%
Glaucoma Severity
20%
Optometrist
20%
Nursing and Health Professions
Systematic Review
100%
Prevalence
100%
Clinical Effectiveness
100%
Cost Effectiveness Analysis
100%
Economic Evaluation
100%
Open Angle Glaucoma
100%
Mass Screening
60%
Visual Impairment
40%
Population
40%
Screening Test
40%
Glaucoma
40%
Base
20%
Patient Referral
20%
Disease Severity
20%
Health Outcomes
20%
Screening
20%
High Risk Population
20%
Quality Adjusted Life Year
20%
Family History
20%
False Positive Result
20%
Optometry
20%
Case Finding
20%
Eye Examination
20%
Eye Care
20%
Optometrist
20%
Medicine and Dentistry
Systematic Review
100%
Health Care Cost
100%
Cost-Effectiveness Analysis
100%
Open Angle Glaucoma
100%
Prevalence
33%
Randomized Controlled Trial
20%
Mass Screening
20%
Glaucoma
13%
Population
13%
Screening Test
13%
Visual Impairment
13%
Patient Referral
6%
Base
6%
Screening
6%
Health Outcomes
6%
Diabetes
6%
Cohort Effect
6%
Family History
6%
High Risk Population
6%
Disease Severity
6%
Quality Adjusted Life Year
6%
False Positive Result
6%
Case Finding
6%
Optometry
6%
Eye Examination
6%
Eye Care
6%
Pharmacology, Toxicology and Pharmaceutical Science
Prevalence
100%
Open Angle Glaucoma
100%
Randomized Controlled Trial
60%
Glaucoma
40%
Visual Impairment
40%
Disease Severity
20%
Base
20%